Rayner is best known for its intraocular lenses (IOLs). It developed the world’s first IOL and is the sole manufacturer of IOLs in the UK. The company currently manufactures 1.3 million lenses a year, but there’s more to the story. Rayner’s portfolio also includes a delivery system, ophthalmic viscosurgical devices, drops, and a digital health platform that captures patient-reported outcomes.
CEO Tim Clover discusses Rayner’s diversified focus and data-driven initiatives with OIS Podcast host Sophia Pathai, MD, PhD. They also talk about how Clover helped move the company in a new direction, which included tearing down one factory and moving into a new R&D, training, and production facility in Worthing, West Sussex, England.
Clover also helped Rayner secure a partnership with Brussels-based HASA OPTIX, which manufactures single-use ophthalmic surgical instruments.
Listen to the podcast to discover:
Click “play” to listen.